Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak.
Piccolo R, Bruzzese D, Mauro C, Aloia A, Baldi C, Boccalatte M, Bottiglieri G, Briguori C, Caiazzo G, Calabrò P, Cappelli-Bigazzi M, De Simone C, Di Lorenzo E, Golino P, Monda V, Perrotta R, Quaranta G, Russolillo E, Scherillo M, Tesorio T, Tuccillo B, Valva G, Villari B, Tarantini G, Varricchio A, Esposito G; Collaborators. Piccolo R, et al. Among authors: monda v. Circulation. 2020 Jun 16;141(24):2035-2037. doi: 10.1161/CIRCULATIONAHA.120.047457. Epub 2020 Apr 30. Circulation. 2020. PMID: 32352318 Free PMC article. Review. No abstract available.
The mitral-to-aortic flow-velocity integral ratio in the real world echocardiographic evaluation of functional mitral regurgitation before and after percutaneous repair.
Palmiero G, Ascione L, Briguori C, Carlomagno G, Sordelli C, Ascione R, Pisacane F, Monda V, Severino S, Caso P. Palmiero G, et al. Among authors: monda v. J Interv Cardiol. 2017 Aug;30(4):368-373. doi: 10.1111/joic.12401. Epub 2017 Jul 3. J Interv Cardiol. 2017. PMID: 28675000 Free article.
Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry.
Moscarella E, Varricchio A, Stabile E, Franzone A, Granata F, Rapacciuolo A, Galasso G, Capozzolo C, Cirillo P, Monda V, Monterforte I, Borgia F, Piro O, Bonzani G, Trimarco B, Esposito G. Moscarella E, et al. Among authors: monda v. Cardiovasc Revasc Med. 2015 Oct-Nov;16(7):401-5. doi: 10.1016/j.carrev.2015.07.008. Epub 2015 Aug 10. Cardiovasc Revasc Med. 2015. PMID: 26342404
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
151 results